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In exposure to toxic metals such as lead, determining lead and cytokine levels (IL-6, IL-10, and TNF-α) is essential for 
early detection of diseases. The aim of this study was to develop an model for early detection of inflammation and onset 
of atherosclerosis in the absence of clinical findings in young workers, which could help physicians take timely an action 
and start treatment. This study included 49 metal workers exposed to lead occupationally and 50 unexposed administrative 
workers (controls) who underwent immunological analysis for cytokines (IL-6, IL-10, and TNF-α) and atherosclerosis 
markers (h-FABP and VCAM-1), toxicological analysis for lead, and routine biochemical analysis (ALT, AST, creatinine) 
at the Ankara Occupational and Environmental Diseases Hospital in 2017. Lead levels correlated with IL-6, IL-10, and 
TNF-α (r=0.469, r=0.521 and r=0.279, respectively, p<0.01) but did not significantly affect h-FABP and VCAM-1 levels.
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Occupational and environmental exposure to metals 
and metalloids can cause many pathological conditions, 
including immunotoxicity. Research has shown that the 
most important mechanism underlying diseases associated 
with lead exposure is inflammation (1–3). Inflammation 
also plays a major role in the development of atherosclerosis 
(4, 5). It acts at all stages, including fatty streak, plaque 
formation, and plaque disruption (6). Since the 1970s, 
a t h e r o s c l e r o s i s  h a s  b e e n  c o n s i d e r e d  a s  a n 
immunoinflammatory disease, in whose development 
cytokines play a key role (7). Cytokines are small proteins 
primarily involved in cellular signalling pathways and 
intracellular inflammatory and immune responses (8). 
Several mechanisms have been proposed to explain how 
lead may cause or aggravate atherosclerosis: by inhibiting 
endothelial physiological functions, by impairing 
angiogenesis, by inactivating nitric oxide, and by increasing 
inflammation through cytokines (9, 10).
Lead exposure has always been an actual topic, 
environmentally and occupationally. Numerous scientific 
studies have shown the link between lead exposure and 
cardiovascular abnormalities such as coronary artery 
disease, atherosclerosis, stroke, peripheral arterial disease, 
and arterial hypertension (11–14). Many have also 
established that lead exposure is closely related to 
inflammation (2, 15, 16) and that it increases pro-
inflammatory cytokine production, including tumour 
necrosis factor-α (TNF-α), interleukin-6 (IL-6), and 
interleukin-10 (IL-10) (17, 18).
To improve atherosclerosis risk prediction, recent 
investigations have focused on the simultaneous use of 
multiple biomarkers. Besides cytokines, some other 
biomarkers could help to establish the adverse effects of 
occupational exposure to lead. In this study we evaluated 
the potential of the vascular cell-adhesion molecule-1 
(VCAM-1) and the heart-type fatty acid binding protein 
(h-FABP) as predictive markers of lead-related 
atherosclerosis. VCAM-1 is an immunoglobulin-like 
adhesion molecule that promotes monocyte adhesion and 
accumulation on the vessel wall (19) and is critical to the 
development of atherosclerotic lesions in animal models 
(20). Fatty acid binding proteins (FABPs) play a key role 
in the transportation of fatty acids and lipophilic molecules 
through the cell membrane. As an intra-cardiac protein, 
h-FABP has been shown to activate inflammation, besides 
indicating myocardial injury (21). There are several studies 
that link this protein to chronic clinical conditions, including 
atherosclerosis (22, 23).
In our study, we aimed to determine the IL-6, IL-10, 
TNF-α, h-FABP, and VCAM-1 levels in lead-exposed 
workers to find their association with blood lead levels and 
standard haematological and biochemical markers 
commonly used to establish adverse effects of occupational 
lead exposure that point to increased risk of inflammation 
and atherosclerosis.
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PARTICIPANTS AND METHODS
Study population and blood sampling
The study included 49 metal recycling workers exposed 
to lead through their occupation and 50 unexposed 
administrative workers, who served as control. The 
inclusion criteria for the exposed group were high blood 
lead levels (BLL>10 µg/dL) (24) and active job in melting 
for more than six months. Persons with acute infections, 
chronic lung disease, diabetes mellitus, diagnosed coronary 
vascular disease, hypertension, rheumatic diseases, or 
cancer were excluded from the study.
Both groups were examined and their blood tested at 
the Ankara Occupational and Environmental Diseases 
Hospital in 2017. Blood samples (one per participant, 
totalling 99) were taken for immunological, toxicological, 
and standard haematological/biochemical analysis at the 
end of the work shift of the last day of work week following 
the American Conference of Governmental Industrial 
Hygienists (ACGIH) industrial toxicological standards (25). 
All procedures followed the 1964 Helsinki Declaration and 
its later amendments. All participants gave their informed 
consent to participate. The study protocol was approved by 
the Clinical Research Ethics Committee of the Yozgat 
Bozok University Faculty of Medicine (approval no. 
12.10.2016/70).
Collection of biological samples and laboratory analysis
Biomarkers were analysed in the sera separated from 
blood samples by centrifugation at 1500 rpm for 10 min 
and then transferred to 2 mL Eppendorf tubes and frozen 
to -20 °C. Frozen samples were transferred to the 
Occupational and Environmental Toxicology Laboratory 
of the Yozgat Bozok University Science and Technology 
Application and Research Center (BILTEM) using a cold 
chain system and stored at -20 °C until analysis.
For IL-6, IL-10, TNF-α, h-FABP, and VCAM-1 analyses 
we used the respective ELISA kits: KAP1261, KAP1321, 
KAP1751 (DIAsource ImmunoAssays SA, Louvain-la-
Neuve, Belgium), DZE201121214, and DZE201120204 
(Shanghai Sunred Biological Technology Co., Shanghai, 
China) and prepared the samples following manufacturer’s 
instructions for each kit. The samples were then placed on 
microplates and fed to a CLARIOstar ELISA plate reader 
(BMG LABTECH, Ortenberg, Germany). The wavelength 
was set at 450 nm. Five-point calibration curves were used 
for all biomarker measurements. The r2 values of the 
calibration curves were 0.9994, 0.9994, 0.9992, 0.9995, 
and 0.9997, respectively. For verification we used standards 
that come with the kits. Linear regression was implemented 
to obtain all biomarker results.
For lead analysis we took 1 mL of the whole blood 
sample, placed in a Teflon tube, added 5 mL of suprapure-
grade 65% nitric acid (HNO3, Merck, Darmstadt, Germany) 
and 5 mL of ultrapure water (Millipore Direct-Q3, Merck), 
and digested in a Milestone Start D microwave digestion 
system (Sorisole, Italy). The digested samples were then 
transferred to 50 mL polypropylene tubes, added deionised 
to obtain the total volume of 20 mL, and stored at +4 °C 
until analysis (26). Lead levels were determined with 
inductively coupled plasma mass spectrometry (ICP-MS; 
iCAP Qc model, Thermo Scientific, Waltham, MA, USA). 
The method was validated with the certified reference 
material (CRM-Seronorm™ Trace Elements Whole Blood 
L-2, Billingstad, Norway) and the r2 value of the calibration 
curve was 0.9998.
Statistical analysis
For statistical analysis we used the Statistical Package 
for Social Sciences version 24.0 (SPSS Inc., Chicago, IL, 
USA). The Mann-Whitney U test was used to determine 
differences in the main parameters between the control and 
exposed group (Table 1). The Pearson test was used to 
determine 2-tailed correlations between cytokine levels and 
toxicological-biochemical variables in both groups. 
Regression analysis was used to understand which of the 
independent variables correlated with lead levels as the 
dependent variable. The levels of statistical significance 
were set at p<0.05 and p<0.01.
RESULTS
Table 1 shows the differences in the main parameters 
between the groups. The two groups significantly differed 
in WBC, AST, Pb, IL-6, IL-10, and TNF-α levels but not 
in h-FABP and VCAM-1 cytokine levels. The exposed 
workers also had shorter working experience than control, 
most likely because of health problems at an early age.
The Pearson correlation (Table 2) showed high positive 
correlations between Pb levels and the IL-6, IL-10, and 
TNF-α cytokine levels (r=0.469, r=0.521, and r=0.279, 
respectively, p<0.01). Pb also positively correlated with WBC 
levels (r=0.252, p<0.01) and negatively with HGB levels 
(r=-0.200, p<0.05). Creatinine negatively correlated with 
IL-10 and TNF-a (r=-0.208 and r=-0.246, respectively, 
p<0.01), and AST negatively correlated with IL-10 (r=-0.020, 
p<0.05).
Regression analysis (Table 3) did not establish any 
significant effects of Pb on VCAM-1 or h-FABP levels, but 
did find a significant correlation between Pb and the 
cytokines. It accounted for the 7.8% change in TNF-α levels, 
the 27.2% change in the IL-10 levels, and the 22.0% change 
in the IL-6 levels (p<0.05).
DISCUSSION
With this study we aimed to develop a model for the 
early detection of inflammation and onset of atherosclerosis 
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in young workers exposed to lead in the absence of clinical 
signs and symptoms. Occupational lead exposure 
significantly reflected on the increased levels of pro-
inflammatory cytokines IL-6, IL-10, and TNF-α but did not 
significantly affect h-FABP and VCAM. A study with 
similar age groups reported BLLs of 9.70±4.20 µg/dL in 
pottery workers and 21.70±8.80 µg/dL in foundry workers 
(27). Both groups of exposed workers had significantly 
higher plasma IL-10 and TNF-α, but not IFN-γ, IL-2, IL-4, 
and IL-6. In contrast, another study (2) reported lower 
TNF-α levels in lead-exposed battery plant workers than 
controls, but not significantly (p>0.05). An environmental 
study (28) that determined the effects of lead on human 
semen reported higher IL-7, IL-10, IL-12, and TNF-α levels 
in a group highly exposed to lead, while the levels of IL-1β, 
IL-2, IL-4, IL-6, IL-8, and IFN-γ did not change 
significantly.
The strong correlations between BLLs and the levels 
of IL-6, IL-10, and TNF-α in our study evidence the 
inflammatory effect of lead, which may lead to the onset 
of atherosclerosis, even though clinical signs and symptoms 
may be absent in young people at the early stage. Our group 
was probably too young to show a correlation between lead 
exposure and h-FABP and VCAM-1. h-FABP is a novel 
biomarker for acute myocardial injury and infarct (29, 30) 
and a predictor of short-term mortality (31). In atherosclerosis 
and inflammation studies about VCAM, there are conflicting 
reports about its predictive potential for early atherosclerosis. 
An old study (32) on human coronary arteries from 
explanted hearts showed no correlation between VCAM-1 
and underlying inflammatory cells. Other studies (33–36) 
have shown that VCAM is a sensitive biomarker for the 
acute coronary syndrome, but the absence of significant 
correlations with the cytokines and BLL in our study suggest 
that it cannot be used as a predictor of atherosclerosis 
associated with occupational exposure to lead.
One limitation of our study was that we did not analyse 
serum nitric oxide levels or other oxidative stress parameters 
mediating lead toxicity. Knowing these parameters could 
have helped us to better understand the cytotoxic effects of 
lead and better interpret the observed inflammation and 
atherosclerosis marker findings. Hopefully one of our future 
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Age (years) 42.00 40.00 33.5–51.25 32.57 31.00 28.00–37.00 523.50 <0.001
BMI (kg/m2) 27.67 27.13 25.69–29.02 26.65 26.82 25.51–27.73 1054.50 0.233
Work duration (years) 13.74 8.00 5.75–24.00 3.29 2.00 1.00–2.00 326.50 <0.001
WBC 7.28 7.02 6.01–8.44 8.12 7.70 7.10–9.43 921.50 0.034
HGB (g/dL) 15.47 15.40 14.90–16.42 14.91 15.30 14.55–15.85 976.00 0.081
HCT (%) 45.87 45.75 43.55–48.25 45.04 45.00 43.35–47.15 1094.50 0.361
PLT (103/µL) 233.46 238.00 209–267 235.98 229.00 186.00–282.00 1224.00 0.994
ALT (U/L) 26.68 22.00 17–28 24.06 19.00 14.00–33.00 1106.00 0.404
AST (U/L) 21.60 20.00 17–25 19.14 19.00 15.00–22.00 963.00 0.046
Creatinine (μmol/L) 0.83 0.82 0.77–0.90 0.81 0.80 0.75–0.90 1057.00 0.235
Pb (µg/dL) 2.73 1.55 1–3.02 21.44 19.30 16.10–26.95 0.000 <0.001
VCAM-1 (ng/mL) 8.55 7.58 4.59–11.14 8.17 7.66 4.80–9.28 1204.00 0.883
h-FABP (ng/mL) 2.52 1.82 1.53–3.01 2.60 1.81 1.61–3.26 1191.00 0.812
TNF-α (pg/mL) 3.70 4.43 1.97–4.94 4.76 4.65 4.13–5.23 871.50 0.013
IL-10 (pg/mL) 33.23 36.54 27.77–39.58 43.69 41.92 39.27–45.97 452.00 <0.001
IL-6 (pg/mL) 24.38 20.49 16.42–27.73 49.34 49.00 34.70–59.08 348.00 <0.001
Significant differences are in boldface (p<0.05 or p<0.001)
Abbreviations: BMI – body mass index; WBC – white blood cells; HGB – haemoglobin; HCT – haematocrit; PLT – platelets; ALT 
– alanine aminotransferase; AST – aspartate aminotransferase; VCAM-1 – vascular cell-adhesion molecule-1; h-FABP – heart-type 
fatty acid-binding protein; TNF-α – tumour necrosis factor alpha; IL-10 – interleukin 10; IL-6 – interleukin 6
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Učinci profesionalne izloženosti olovu na izabrane upalne biomarkere
Pri izloženosti toksičnim metalima poput olova, utvrđivanje razina olova i upalnih citokina (IL-6, IL-10 i TNF-α) ključno 
je za rano otkrivanje bolesti. Cilj je ovoga ispitivanja bio osmisliti model za rano otkrivanje upala i ateroskleroze u mladih 
radnika profesionalno izloženih olovu dok se još nisu pojavili klinički znakovi i simptomi. Zahvaljujući tomu, liječnici 
bi mogli pravovremeno započeti liječenje. Ispitivanje je obuhvatilo 49 metalskih radnika izloženih olovu i 50 neizloženih 
administrativnih radnika (kontrolna skupina) koji su bili podvrgnuti imunološkim testovima na citokine (IL-6, IL-10 i 
TNF-α) i na markere ateroskleroze (h-FABP i VCAM-1), toksikološkomu testu na olovo te rutinskim biokemijskim 
testovima (ALT, AST, kreatinin) u Bolnici za profesionalne i okolišne bolesti u Ankari 2017. Razine olova u krvi korelirale 
su s razinama IL-6, IL-10 odnosno TNF-α (r=0,469, r=0,521, odnosno r=0,279, p<0,01), ali nisu značajno utjecale na 
razine h-FABP odnosno VCAM-1.
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